Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-013358

Chief Financial Officer sold 399 shares at $8.76 ($3,495)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Trigilio Jeffrey Chief Financial Officer 2023-05-18 Sale −399 $8.76 $3,495 86,541 D
Open-market sales · 399 sh · avg $8.76 · $3,495
Loading xslF345X04/doc4.xml…